In the UK vaccinations using two main vaccine options Pfizer BioNTech and Oxford-AstraZeneca are well under way in the most vulnerable age groups, those over 70 and those with the highest risk of exposure to covid-19 infection such as healthcare workers and those in care homes looking after vulnerable residents.

Staff Update

Staff members of MS Research are now working from home and continue to raise funds to help improve the treatment and lives of those living with MS. The Vassall Centre where MS Research offices are located have been made COVID-safe for when it is necessary for staff members to be in the office.

MHRA announced approval for the Oxford/Astra-Zeneca vaccine to cheer up the last few days of 2020.

Approval by MHRA*, the medicines regulatory body in the UK, of the first of the new vaccinations against Covid-19 has been announced today.